| Pharmacokinetics of Y-4 Tablets With Pregabalin Capsules and Riluzole Tablets in U.S. Healthy Participants (NCT07618715) | Neurodawn Pharmaceutical Co., Ltd. | 2026-06-30 |
| Phase I/II Study of Anti-CD38 Monoclonal Antibody in Refractory Severe Aplastic Anemia (NCT07714512) | Institute of Hematology & Blood Diseases Hospital, China | 2026-06-30 |
| A Phase I Clinical Study to Evaluate the Safety, Tolerability, and PK of HLX48 in Advanced/Metastatic Solid Tumors (NCT07473726) | Shanghai Henlius Biotech | 2026-06-30 |
| Human ADME Study of [14C]-AZD1390 (NCT07643870) | AstraZeneca | 2026-06-30 |
| A Phase 1 Study to Evaluate the Safety and Efficacy of OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer. (NCT07664735) | Outpace Bio, Inc. | 2026-06-30 |
| Savolitinib Plus Cetuximab and FOLFOX Chemotherapy for RAS/BRAF Wild-type Metastatic Colorectal Cancer (NCT07683403) | Fudan University | 2026-06-30 |
| ABY-029 Head & Neck Trial (NCT07279116) | Dartmouth-Hitchcock Medical Center | 2026-06-30 |
| Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC (NCT05403723) | University of Maryland, Baltimore | 2026-06-30 |
| Study of ERW316 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors (NCT07570966) | Novartis Pharmaceuticals | 2026-06-30 |
| PD-1 Antibody and JAK1 Inhibitor for Newly Diagnosed Pediatric Hodgikin's Lympoma (NCT07641010) | Shanghai Jiao Tong University School of Medicine | 2026-06-30 |
| Nelmastobart in Combination With Tas-102 and Bevacizumab in Recurrent/Metastatic Colorectal Cancer (NCT07656038) | STCube, Inc. | 2026-06-30 |
| A Clinical Study of MK-8527 in Healthy Participants (MK-8527-021) (NCT07661108) | Merck Sharp & Dohme LLC | 2026-06-30 |
| A Clinical Study of ZL-85FA Tablets (NCT07339748) | Chengdu Zenitar Biomedical Technology Co., Ltd | 2026-06-30 |
| Phase I Study of HRS-1635 in B-cell Malignancies (NCT07583212) | Chengdu Suncadia Medicine Co., Ltd. | 2026-06-30 |
| A Phase Ib Study of Tislelizumab Plus SYS6010 in Immunotherapy-Pretreated Locally Advanced or Metastatic NSCLC (NCT07692048) | Sichuan University | 2026-06-30 |
| Phase 1, Safety and Tolerability Study of XmAb541 and XmAb808 in Advanced Solid Tumors (NCT07593092) | Xencor, Inc. | 2026-06-30 |
| Study of NTB-928 in R/R OC (NCT07690189) | TeneoSeven, Inc. | 2026-06-29 |
| AMT-116 in Combination With AK112 in Patients With Lung Cancer (NCT07590531) | Multitude Therapeutics Inc. | 2026-06-29 |
| A Study to Learn How the Study Medicine Called Atirmociclib is Handled by the Body in People With Normal Liver Function and Different Levels of Liver Disease (NCT07677358) | Pfizer | 2026-06-29 |
| Neoadjuvant Immunotherapy for Patients With High-risk Eye Melanoma (NCT07501117) | Inge Marie Svane | 2026-06-29 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics and Clinical Activity of BBT001 Following Intravenous Administration in Participants With Chronic Spontaneous Urticaria (CSU) (NCT07717905) | Bambusa Therapeutics | 2026-06-29 |
| Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity (NCT07594093) | Regeneron Pharmaceuticals | 2026-06-29 |
| Study of Single and Multiple Oral Doses of SCB0020160 in Healthy Adult Male Subjects (NCT07682337) | SCBIO Inc. | 2026-06-29 |
| An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis (NCT07665723) | Hoffmann-La Roche | 2026-06-29 |
| Safety of MOON101 for the Treatment of Peanut Allergy (NCT07580898) | Moonlight Therapeutics, Inc. | 2026-06-29 |
| A Study to Evaluate the Safety and Pharmacokinetics of AZD7760 in Healthy Japanese Adults (NCT07612813) | AstraZeneca | 2026-06-29 |
| Study to Assess [177Lu]Lu-PSMA-R2 (AAA602) and [225Ac]Ac-PSMA-R2 (AAA802) in Participants With PSMA-positive HRLPC (NCT06881823) | Novartis Pharmaceuticals | 2026-06-29 |
| Dimotec (Diosmin) 1000 mg Film Coated Tablet Fed Study (NCT07674446) | Keri Pharma Hungary Kft | 2026-06-29 |
| BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants (NCT06741072) | Ohio State University Comprehensive Cancer Center | 2026-06-28 |
| An Open-label, Fixed-sequence Phase I Clinical Trial to Evaluate the Effect of HS-10504 on the Pharmacokinetics of Midazolam in Patients With Non-small Cell Lung Cancer (NCT07685041) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2026-06-27 |
| Study of SNH-118110 in Advanced Solid Tumors (NCT07649200) | ScinnoHub Pharmaceutical Co., Ltd. | 2026-06-26 |
| A Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung Cancers (NCT07117214) | Novartis Pharmaceuticals | 2026-06-26 |
| Single Ascending and Multiple Ascending Dose Study of LCA-0061 (NCT07701954) | Lycia Therapeutics, Inc. | 2026-06-26 |
| A First-in-Human Study of HP-002 for Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (NCT07658352) | Shanghai Helioson Pharmaceutical Co., Ltd. | 2026-06-26 |
| A Phase 1 Study to Evaluate the Relative Bioavailability of Octreotide Acetate Tablets(T25) Compared to MYCAPSSA® and The Food Effect on Pharmacokinetics Of Octreotide Acetate Tablets(T25) (NCT07663318) | Triastek (Shanghai) Limited | 2026-06-26 |
| A Trial to Assess TEV-56286 at Different Doses in Healthy Participants (NCT07674940) | Teva Branded Pharmaceutical Products R&D LLC | 2026-06-26 |
| Drug-Interaction Assessment of GSK3772701 in Healthy Male and Female Participants Aged 18 to 55 Years (NCT07670377) | GlaxoSmithKline | 2026-06-26 |
| Phase 1b/2: Isatuximab, Iberdomide, Bortezomib, Dexamethasone in Transplant Ineligible/Deferred Newly Diagnosed Myeloma (NCT07601100) | Dana-Farber Cancer Institute | 2026-06-26 |
| A Positron Emission Tomography Study to Assess the Occupancy of M4 Muscarinic Acetylcholine Receptors by BMS-986521 in Healthy Adult Participants (NCT07655518) | Bristol-Myers Squibb | 2026-06-25 |
| Safety and Efficacy of SUM-191 for Patients With Bacterial Conjunctivitis (NCT07565103) | Senju USA, Inc. | 2026-06-25 |
| GPRC5D Targeted PET/CT Imaging in Plasma Cell Disorders (NCT07660939) | Peking University First Hospital | 2026-06-25 |
| Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV (NCT07040319) | National Institute of Allergy and Infectious Diseases (NIAID) | 2026-06-25 |
| A First-In-Human Study of ARO-033 in Adult Participants (NCT07662096) | Arrowhead Pharmaceuticals | 2026-06-25 |
| JL19001 Injection Alone or in Combination With Standard Therapy in Patients With Advanced Solid Tumors or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (NCT07603479) | Jecho Biopharmaceuticals Co., Ltd. | 2026-06-25 |
| A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer (NCT05521698) | University of Wisconsin, Madison | 2026-06-25 |
| A First-in-Human Study of ZE94-0605 in Patients With Advanced Solid Tumors (NCT07524140) | Eilean Therapeutics | 2026-06-25 |
| Safety and Food Effect on Single-Dose Bioavailability of F-02-2-Na in Healthy Adult Subjects (NCT07346027) | Guangdong Hengqin Novagains Biopharmaceutical Co., Ltd. | 2026-06-25 |
| Prospective, Randomized, Sham-controlled, Dose-finding I/II Trial of Safety and Efficacy of Modified Optogenetic Gene Therapy (ZM-02 Injection) (NCT07282457) | Zhongmou Therapeutics | 2026-06-25 |
| U69-CART-Cells For R/R T-ALL (NCT07350863) | The First Affiliated Hospital of Soochow University | 2026-06-25 |
| 18F-grazy-02 PET/CT of Granzyme B Expression for Monitoring Immunotherapy (NCT07724535) | Peking University Cancer Hospital & Institute | 2026-06-24 |
| A Study of Eloralintide (LY3841136) in Participants With Overweight or Obesity (NCT07665879) | Eli Lilly and Company | 2026-06-24 |
| A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors (NCT07705334) | SHY Therapeutics | 2026-06-24 |
| A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy (NCT07654972) | Eli Lilly and Company | 2026-06-24 |
| A Study to Assess Safety, Tolerability, and How Single and Multiple Injections or Infusions of ABBV-313 Affects the Body of Adult Participants (NCT07673120) | AbbVie | 2026-06-24 |
| A Study to Evaluate the Safety, Reactogenicity, and Immune Response of the GSK Vaccines Institute for Global Health (GVGH) Quadrivalent Pan-Salmonella Vaccine With and Without Alum in Healthy Young Adults (NCT07663032) | GlaxoSmithKline | 2026-06-24 |
| Safety and Efficacy of Intrathecal Sacituzumab Tirumotecan for Leptomeningeal Metastasis in EGFR-TKI-Resistant Non-Small Cell Lung Cancer (NCT07702305) | Henan Cancer Hospital | 2026-06-23 |
| A Study to Assess Nipocalimab Concentrations in Breast Milk of Healthy Lactating Women (NCT07669077) | Janssen Research & Development, LLC | 2026-06-23 |
| A Study to Evaluate How Multiple Doses of Itraconazole Interacts With Nacresertib in Healthy Adult Participants (NCT07649954) | AbbVie | 2026-06-23 |
| A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21) (NCT07302347) | Merck Sharp & Dohme LLC | 2026-06-23 |
| A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies. (NCT07389239) | University of Chicago | 2026-06-23 |
| Phase 1 Study on the Safety, Tolerability, and Pharmacokinetics of JST-018 in Healthy Adults (NCT07595458) | Just-Evotec Biologics | 2026-06-23 |
| Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas (NCT07468136) | Mayo Clinic | 2026-06-23 |
| An Investigational Study of BG-75202 Alone and in Combination With Other Agents in Patients With Myeloid Malignancies (NCT07619287) | BeOne Medicines | 2026-06-23 |
| A Study to Evaluate RO7851624 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (NCT07558915) | Genentech, Inc. | 2026-06-23 |
| AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980) (NCT07158905) | Institute for Molecular Medicine | 2026-06-23 |
| Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors (NCT07630961) | Novartis Pharmaceuticals | 2026-06-23 |
| A Study Testing the Safety and Effects of FB102 in Healthy Volunteers (NCT07623057) | Forte Biosciences, Inc. | 2026-06-23 |
| Bioequivalence (BE) Study Between YHP2511 and YHP2511A in Healthy Volunteers (NCT07470125) | Yuhan Corporation | 2026-06-23 |
| A Study in Healthy Men to Test How Bosentan Influences the Amount of Zongertinib in the Blood (NCT07649941) | Boehringer Ingelheim | 2026-06-22 |
| Study of JAB-23E73 in Combination With Chemotherapy in Participants With Metastatic PDAC Harboring KRAS Gene Alterations (NCT07640295) | Jacobio Pharmaceuticals Co., Ltd. | 2026-06-22 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MWX205 (NCT07634510) | Shanghai Minwei Biotechnology Co., Ltd | 2026-06-22 |
| A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer (NCT07671339) | Memorial Sloan Kettering Cancer Center | 2026-06-22 |
| An Early-stage Clinical Trial to Evaluate the Safety, Absorption, and Disposition of YR001 Ointment Following Topical Application on the Skin of Healthy Chinese Subjects (NCT07673458) | Hangzhou Yirui Pharmaceutical Technology Co., Ltd | 2026-06-22 |
| A Study of ARC-02 in B-cell NHL (NCT07691606) | Taiho Oncology, Inc. | 2026-06-22 |
| A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202) (NCT07602777) | GlaxoSmithKline | 2026-06-22 |
| Study to Evaluate the Effect of Food and a Proton Pump Inhibitor on the Pharmacokinetics of VRN101099 in Healthy Adult Participants (NCT07550946) | Voronoi, Inc | 2026-06-22 |
| GenSci144 Tablets Phase I Clinical Trial (NCT07685210) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2026-06-22 |
| A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects (NCT07675590) | TIXiMED, Inc. | 2026-06-22 |
| The STem Cell-derived Extracellular Vesicle Therapy In Acute Ischemic Stroke (STEVIA) (NCT06995625) | S&Ebio Co. Ltd. | 2026-06-22 |
| Simple Non-cultured Endothelial Cell Therapy for Corneal Endothelial Dysfunction (NCT07711561) | Singapore Eye Research Institute | 2026-06-22 |
| A Trial to Compare What the Body Does to Selatogrel and the Effect of Selatogrel in Chinese Adults With Chronic Coronary Syndrome (NCT07615868) | Viatris Innovation GmbH | 2026-06-22 |
| Peptide Nanovaccine (ONVAX-01) Plus Anti-PD-1 Antibody and Chemotherapy in Advanced Pancreatic Cancer (NCT07637786) | Sichuan University | 2026-06-20 |
| Phase 1, First in Human (FIH), Open-Label, Single-Arm, Ascending Dose Study to Assess the Safety, Tolerability and Preliminary Immunogenicity of ITI-9001 in Japanese Patients With Japanese Red Cedar (JRC) Pollinosis (NCT07726147) | Immunomic Therapeutics, Inc. | 2026-06-20 |
| Gene-Modified Stem Cell Therapy for Children With Autosomal Recessive Osteopetrosis (ARO) (NCT07665021) | Fondazione Telethon | 2026-06-20 |
| A Study to Evaluate Ibuprofen (IBU) 62.5 mg and Acetaminophen (APAP) 125 mg/5 ml in an Oral Liquid Suspension Fixed-Dose Combination Product in Children Aged 6 to 11 Years (NCT07632274) | HALEON | 2026-06-19 |
| A Randomized, Double-Blind, Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma (NCT07475572) | Alvotech Swiss AG | 2026-06-19 |
| A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Subcutaneous UBT38006 Injection in Healthy Adult Males (NCT07630233) | The United Bio-Technology (Hengqin) Co., Ltd. | 2026-06-19 |
| A Clinical Study to Evaluate JCXH-213 in the Treatment of Adults With Primary Immune Thrombocytopenia (NCT07622329) | The General Hospital of Western Theater Command | 2026-06-18 |
| Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001) (NCT07600749) | Merck Sharp & Dohme LLC | 2026-06-18 |
| IAP-086-1: A Phase 1 Single Ascending Dose First-Time in Human Study (NCT07596888) | University of North Carolina, Chapel Hill | 2026-06-18 |
| A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic Retinopathy (NCT07588100) | Hoffmann-La Roche | 2026-06-18 |
| CW-301 FIH Study of CAN016 (NCT07664150) | Canwell Biotech Limited | 2026-06-18 |
| A Phase I/II Trial of JR-446 in Mucopolysaccharidosis Type IIIB (MPS IIIB) (NCT07640984) | JCR Pharmaceuticals Co., Ltd. | 2026-06-18 |
| Evaluation of the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of BBM-C101 Injection in Patients With Cervical High-Grade Squamous Intraepithelial Lesion(HSIL) (NCT07668960) | Shanghai Mianyi Biopharmaceutical Co., Ltd. | 2026-06-17 |
| First-in-human Study of HSK56630 in Healthy Subjects (NCT07580794) | Haisco Pharmaceutical Group Co., Ltd. | 2026-06-17 |
| Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation (NCT07012031) | National Cancer Institute (NCI) | 2026-06-17 |
| A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma (NCT07660731) | Pfizer | 2026-06-17 |
| A First-in-Human SAD/MAD Study to Evaluate Safety, Tolerability and PK of ENC0653 Ointment in Healthy Adult Subjects (NCT07684196) | EnnovaBio | 2026-06-17 |
| A Study to Investigate the Relative Bioavailability and Food Effect of Tablet for Oral Suspension of Sonrotoclax in Healthy Adults (NCT07628881) | BeOne Medicines | 2026-06-17 |
| A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM) (NCT07501559) | Jecho Biopharmaceuticals Co., Ltd. | 2026-06-17 |